Rick Simpson Oil (RSO) in Dooly County, Georgia: The Complete Guide by OilWell Cannabis

If you live in Dooly County, Georgia — whether you’re tending peanut fields outside Vienna, working the catfish farms near Pinehurst, or caring for family in Unadilla — you’ve probably heard whispers about Rick Simpson Oil. Maybe a neighbor mentioned it at the Piggly Wiggly. Maybe you saw it discussed in a cancer support group online. Maybe you’re one of the many veterans in our area who’ve been searching for something, anything, that helps with the pain and sleepless nights when the VA’s pills stop working.

We get it. Dooly County is a place where people take care of their own. Where you don’t ask for help unless you really need it. Where “I’ll be fine” is as common as summer thunderstorms. But sometimes being fine means finding real answers, not just the ones that are easy to get.

That’s why we at OilWell Cannabis — a Houston-based company built from the ground up by people who’ve been through hell and back — created this guide specifically for Dooly County residents. We’re not here to sell you snake oil or false hope. We’re here to give you the most complete, honest, science-based education about Rick Simpson Oil available anywhere, and to show you how our modern, legal, multi-cannabinoid RSO formula can reach your doorstep in Dooly County within days.

ABOUT RICK SIMPSON AND TRADITIONAL RSO

Who Was Rick Simpson, Really?

Born in 1949 in Amherst, Nova Scotia, Rick Simpson was no doctor, no scientist, no researcher. He was a power engineer and maintenance worker — a blue-collar tradesman who, like many folks in Dooly County, believed in solving problems with his own hands when the system failed him. In 1997, while working at a hospital in Moncton, he fell from scaffolding and suffered a serious head injury that left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t fix.

The medications doctors prescribed either didn’t help or made things worse. When Simpson found that cannabis provided more relief than anything else, he asked his physician to support or prescribe it. The doctor refused. Sound familiar? How many people in Dooly County have been told “there’s nothing more we can do” by a doctor who won’t even discuss cannabis as an option?

Simpson’s interest deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to show harm — became his touchstone, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Instead of pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification was ever published. No biopsy confirmation. No clinical follow-up in any peer-reviewed source. But this personal experience became the origin story of Rick Simpson Oil and sparked a global movement.

Important context we must share: Simpson’s account is personal testimony, not medical evidence. The absence of clinical documentation means these events cannot be evaluated as scientific proof. They are, however, historically significant as the catalyst for a movement that eventually reached places like Dooly County, Georgia.

The Crusade: Spreading the Oil

After 2003, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free — no charge, no profit — to cancer patients and others in his community. By his account, he helped dozens of people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more.

His story reached a global audience through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. For many, it was their first introduction to concentrated cannabis oil as medicine.

But his advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, living in Croatia and the Netherlands, continuing his advocacy from abroad.

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform. Throughout his career, his position remained consistent: cannabis oil could cure cancer and many other diseases, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge.

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. We present it here to understand the cultural significance of RSO, not to endorse or dismiss it. We know that institutional distrust runs deep in rural Georgia, especially in agricultural communities that have watched government policies favor corporations over family farms. That skepticism is understandable, but it must be balanced with honest science.

The Traditional RSO Protocol: Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was to consume 60 grams of concentrated cannabis oil over approximately 90 days. Here’s exactly what he prescribed:

Goal: 60 grams of oil in ~90 days, considered the minimum for serious cancer treatment.

Titration Schedule:

• Week 1: Half a grain of rice-sized dose (10-15 mg) three times daily. Total: 30-45 mg/day.
• Weeks 2-5: Double the dose every four days, building tolerance gradually. Target: 1 gram (1,000 mg) per day by week 5, divided into three 333 mg doses.
• Weeks 5-12: Maintain 1 gram/day until all 60 grams are consumed.

Administration Methods:

• Oral: Primary route — sublingual or swallowed for systemic absorption.
• Topical: For skin cancers, applied directly and covered with bandages.
• Inhalation: Not recommended as primary treatment, but acknowledged for immediate symptom relief.

Tolerance and Psychoactive Effects:

• Simpson claimed patients develop tolerance within 3-4 weeks.
• He recommended nighttime dosing initially to sleep through the high.
• He warned against driving during titration.

Post-Protocol Maintenance: 1-2 grams per month indefinitely.

Important Context for Evaluating This Protocol:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or case series support this specific protocol for any condition.
• Crude, unstandardized material. Every batch varied based on starting plant material and extraction technique.
• Very high THC exposure. At peak dosing (1 gram/day of 60-90% THC oil), patients consumed 600-900 mg of delta-9 THC daily — far exceeding controlled clinical settings. For context, FDA-approved dronabinol is typically dosed at 2.5-20 mg/day.
• Real risks at these doses. 600-900 mg of THC daily carries severe risks: intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are medically complex. Using unregulated cannabis oil as primary treatment — potentially instead of proven therapies — introduces genuine harm.

What Traditional RSO Actually Was

Source Material: High-THC indica strains, single-strain, no standardization.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol — neither food-grade.

Extraction Process: Bucket, solvent wash, filter through cheesecloth, evaporate in rice cooker, transfer to syringes.

Appearance: Nearly black, thick, tar-like, strong cannabis odor, possible solvent-residual smell.

Cannabinoid Profile: THC-dominant (60-90% estimated), fully decarboxylated, minor cannabinoids at natural ratios — uncontrolled, unmeasured, never lab-verified.

Terpene Content: Minimal to none. The solvent + heat process destroyed terpenes.

Standardization and Testing: None. Every batch was different. No COA, no quantification, no contaminant screening.

Residual Solvent Risk: Naphtha may contain benzene, toluene, xylene — toxic and carcinogenic. Incomplete purging leaves harmful residues.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. Let’s evaluate this against actual evidence.

What Simpson Was Not:

• Not a scientist, physician, pharmacologist, or researcher.
• No formal medical or research training.
• Never conducted or published a clinical trial.
• Never submitted results to peer review.
• Evidence base: personal experience and informal testimonials only.

What Preclinical Literature Shows:

• In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines .
• Animal models show some tumor-growth inhibition in mice and rats .
• These findings are scientifically interesting and warrant continued research.

What Preclinical Literature Does NOT Show:

• These findings have NOT translated into proven human cancer cures.
• The gap between animal/in vitro results and human outcomes is vast.
• No human clinical trial has demonstrated RSO or any cannabis oil cures cancer .

Institutional Positions:

• National Cancer Institute (NCI): Acknowledges cannabinoids have been studied for anticancer effects in labs and animals, but does NOT endorse cannabis or cannabis oil as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD) for seizures and dronabinol/nabilone (synthetic THC) for chemo nausea and AIDS wasting are approved [1].
• Health Canada: Never approved RSO or cannabis oil as cancer cure.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1].

What Simpson Got Right:

• Drew attention to cannabinoids as serious biomedical research when the world ignored it.
• Helped create conditions for legal cannabis industry and research infrastructure.
• “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated:

• Cancer cure claims exceeded evidence then and still do now.
• Encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential.
• Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

The Legacy and Modern Evolution

Today, “RSO” is used loosely across the legal cannabis industry. Many products bear little resemblance to Simpson’s original. The term has become generic.

Simpson himself criticized commercial products that depart from his method and philosophy. He believed in DIY, free-access models — grow your own, make your own, no corporate intermediaries.

The modern industry has commercialized, standardized, and regulated what Simpson gave away. Whether that’s improvement (quality control, lab testing, dosing precision) or betrayal (profit extraction, regulatory gatekeeping) depends on perspective.

What is not in dispute: modern RSO has evolved substantially, and those changes matter for your health and safety.

TRADITIONAL RSO VS. MODERN FORMULATED RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene Content	Destroyed by high heat	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual Solvents	Significant risk with naphtha	Controlled and tested — none present
Dosing Precision	Approximate, syringe-based	Measured per mL: 553mg total cannabinoids/mL
Product Formats	Single thick oil only	Sublingual oil AND vape cartridge
THCa Preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500mg
Delta-9 THC Dominance	60-90% of content	Only 90mg total (3mg/mL) — dramatically lower
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Multi-Cannabinoid Approach: Traditional RSO relied on whatever single strain the maker grew. Our formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene Preservation: Traditional RSO had essentially no terpenes due to heat destruction. We include live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene — because terpene bioactivity is plausible at the preclinical level, even if human clinical confirmation is still developing [20][21][23][24][25][26][27][28][29].

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

Reduced Delta-9 THC Dominance: Traditional RSO was overwhelmingly delta-9 THC (60-90%). Our sublingual formula uses delta-9 THC at only 90mg while distributing the remaining cannabinoid content across CBD (4,500mg), CBG (3,000mg), delta-8 THC (6,000mg), CBN (750mg), and CBC (750mg). This reflects the broader cannabinoid research landscape rather than single-compound dominance.

Product Format Innovation: Simpson envisioned only one format — oral oil from a syringe. We offer both a 30mL sublingual oil and a 1-gram vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

ABOUT OILWELL CANNABIS AND OUR RSO FORMULA

Our Origin: From McAllen to Houston to Dooly County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our story begins far from the Texas Medical Center — in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. It’s a place where opportunities are scarce outside of retail and healthcare, where poverty and cartel violence shape daily life, where a young man learns to hustle just to survive.

Colin’s childhood was marked by every form of violence imaginable. By sixteen, he’d already lost best friends to prison or death. He had to leave home for good. He learned to transport items across the border, navigating dangers most people in Dooly County have never faced. But here’s what matters: despite those dangers, Colin never fell into the darkest paths. He focused on cannabis, seeing it as a safer, more beneficial alternative to the harder substances that destroyed so many lives around him.

He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Later, he became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — defines everything we do.

Bentley’s Story: The Real Reason We Exist

Our company’s origin begins with a dog named Bentley. Bentley was more than a pet — he was family, the companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” asked a rescue worker named Jessica.

That question exposed a blind spot that became our mission. Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was not a cure, but it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork. This is why our RSO contains seven cannabinoids, not one or two. It wasn’t a marketing decision. It was born from necessity.

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form to manage his insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits Colin first discovered through Bentley became the core of his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston: Seven Features, Five Reporters, Four Years

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought us out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers.

No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

September 15, 2019 — Texas CBD businesses booming: This was our first ABC13 feature. Colin’s quote from that day captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 22, 2021 — Decriminalization efforts: Colin described how “pain comes in a lot of different forms,” highlighting the therapeutic dimension beyond just getting high. This resonated with veterans and chronic pain patients across Texas and beyond.

May 24, 2021 — Delta-8 THC investigation: Steve Campion’s investigative feature included Colin’s iconic exchange: “Maybe you want to get high” — radical honesty on mainstream television that balanced Dr. Weaver’s medical caution and Heather Fazio’s regulatory advocacy.

August 20, 2021 — COVID vaccine giveaway: We gave away 1,000 special edition caviar pre-rolls (approximately $35,000 in product) to encourage vaccination in Houston. We coordinated with the city government. No political strings attached. This wasn’t marketing — it was documented community health action.

October 19, 2021 — Delta-8 ban: When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and tried to warn other operators who were unknowingly shipping Schedule I narcotics. We absorbed a major revenue loss to act ethically.

October 7, 2022 — Biden marijuana pardon: This feature revealed Colin’s personal marijuana conviction history. He said, “I would love to see people not get hurt for this anymore.” This transforms our entire media record — we’re not outside entrepreneurs; we’ve lived the consequences of cannabis criminalization.

April 21, 2023 — Texas marijuana industry: Colin described the present as a “Renaissance” that should be enjoyed now, positioning OilWell at the frontier of a changing industry.

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That kind of recognition cannot be purchased — only earned.

OilWell Today: Licensed, Verified, Delivering to Dooly County

Today, OilWell Cannabis operates from Montrose, Houston, Texas at 810 Richmond Avenue, Houston, TX 77006. We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed.

All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do. Our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

And yes — we deliver to Dooly County, Georgia.

THE OILWELL RSO PHILOSOPHY

OilWell’s RSO is not traditional RSO. It’s a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways designed to solve the problems that limited Simpson’s original vision.

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For Dooly County residents, this is revolutionary. Georgia’s medical cannabis program (TCUP) is one of the most restrictive in the nation — only about 10,000 active patients in a state of 10 million people. By comparison, Florida, with two-thirds of Texas’s population, has 700,000 medical cannabis patients. If you live in Vienna, Lilly, or anywhere in Dooly County, you likely don’t qualify for Georgia’s program even if you have cancer, chronic pain, or PTSD.

Our Farm Bill-compliant RSO sublingual oil requires no medical card, no qualifying condition, no state registry. We can ship it directly to your door in Dooly County because it contains less than 0.3% delta-9 THC by dry weight — fully legal under federal law.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

For Dooly County residents who work in agriculture, drive tractors, operate machinery, or simply need to function during the day, this is crucial. You can use the raw form sublingually for anti-inflammatory benefits without any psychoactive impairment. Then, when you’re home for the evening and ready for stronger effects, you can decarboxylate a portion for full potency.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away for free; we adapted that ethos for the modern marketplace by selling a professionally manufactured product AND publishing the recipe.

For Dooly County residents living on fixed incomes, dealing with medical bills from treatment at Crisp Regional Hospital or trips to Macon specialists, affordability matters. Our $129.99 sublingual oil (30mL, 16,590mg total cannabinoids) or $49.99 vape cartridge may be out of reach. But the formula is free. You can see exactly what’s in it and, if you have the means and knowledge, create your own version.

Simpson’s original golden paste recipe that saved Bentley — the one we published years before our RSO formulas — is still available on our website for pet owners in Dooly County facing similar crises with their companions.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

We don’t hide behind vague claims. We cite specific studies, explain evidence tiers, and tell you when the data is weak or incomplete. That’s the OilWell difference.

FARM BILL COMPLIANCE AND THE THCa LEGAL FRAMEWORK

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Georgia.

Here’s where it gets powerful for Dooly County residents: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is NOT itself delta-9 THC. At the point of sale, THCa is Farm Bill compliant because it hasn’t been converted.

The Conversion Process:
You can legally purchase our product in Dooly County, then decarboxylate the THCa at home:

• Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container.
• This converts 1,500mg of THCa into approximately 1,315mg of delta-9 THC.
• Combined with the existing 90mg of delta-9 THC, you get ~1,405mg total delta-9 THC.
• Combined with 6,000mg of delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs at YOUR discretion after purchase.

Important Legal Notice for Dooly County Residents:
THCa converts to delta-9 THC when heated. As a Dooly County customer, you are responsible for understanding and complying with Georgia state law regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International and out-of-state customers accept all customs and legal risk.

Georgia law can be complex. While our product is federally legal, we encourage Dooly County residents to verify current state regulations. As of 2025, Georgia’s hemp laws align with federal Farm Bill provisions, but local interpretations can vary.

OPEN-SOURCE FORMULAS: WHY WE PUBLISH EVERYTHING

We publish our complete RSO formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own. This is a direct echo of Rick Simpson’s original ethos.

If you live in Dooly County and $129.99 for our sublingual oil or $49.99 for our vape cartridge is beyond your budget, you can see exactly what’s in it:

• 4,500mg CBD
• 3,000mg CBG
• 6,000mg Delta-8 THC
• 1,500mg THCa
• 90mg Delta-9 THC
• 750mg CBN
• 750mg CBC
• 5% live terpenes in organic MCT oil

You can source individual cannabinoid distillates and isolates from hemp suppliers (many operate online and ship nationwide), blend them at these exact ratios, and create your own version. We don’t hide our formula as “proprietary.” We want you to have access, whether you buy from us or make it yourself.

This philosophy started with Bentley. We published the CBD golden paste recipe that saved his life so any pet owner in Dooly County — or anywhere — facing a similar crisis could try it. That recipe is still on our website, free for anyone to use.

THE DECARBOXYLATION CHOICE: YOUR CONTROL OVER POTENCY

Traditional RSO was always fully decarboxylated. The heat converted all THCa to THC, leaving you with no choice about psychoactivity.

Our sublingual formula creates three distinct usage options:

Option 1 — Raw, No Heat: All 1,500mg stays as THCa — completely non-psychoactive. The THCa evidence suggests anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with work, driving, and daytime use with zero impairment. Perfect for Dooly County residents who operate farm equipment, drive trucks, work construction, or need to stay sharp.

Option 2 — Fully Activated, Home Decarboxylation: Heat at 260°F for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 THC, you get ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, this delivers psychoactive potency comparable to traditional illegal RSO — 100% legally, because activation happens after purchase. You can decarboxylate the entire bottle or just a portion in a separate container, preserving the rest raw.

Option 3 — Vape, Auto-Decarboxylation: Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method — 1-2 minute onset for breakthrough symptoms.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule.

This design puts the potency decision entirely in your hands — aligning with Simpson’s principle that patients should control their own medicine, but implementing it through actual chemistry.

SOLVENT-FREE PRODUCTION

Traditional RSO production used naphtha or isopropyl alcohol — neither food-grade, both carrying significant residual solvent risk. This is one of the most dangerous aspects of DIY RSO.

Our RSO is not an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined in a controlled production environment. No solvents are present in the finished product.

We use organic MCT oil (medium-chain triglycerides) as the carrier base, a food-grade lipid that facilitates sublingual absorption and provides a neutral taste — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-Party Lab Testing: Every batch is tested for:

• Cannabinoid potency (verified to ±2% accuracy via HPLC/UHPLC)
• Terpene profile
• Pesticides (400+ compound screening via LC-MS/MS and GC-MS/MS)
• Heavy metals (arsenic, cadmium, lead, mercury via ICP-MS)
• Residual solvents (FDA Class 3 limits <5,000 ppm via headspace GC)
• Microbial contaminants (E. coli, Salmonella, Aspergillus)

Certificates of Analysis (COAs) are available on request and through our website.

THE OILWELL PRODUCT PORTFOLIO

Beyond RSO, we produce cannabinoid products developed from Colin’s formulation knowledge:

Asshole Peach — Our most popular product. Carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for PTSD and pain relief. Contains 268mg total cannabinoids per ring: 28mg Delta-9 THC, 50mg Delta-8 THC, 20mg Delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG.

Peace Gummies — Developed directly from Colin’s PTSD and benzodiazepine withdrawal experience. Helped him quit Xanax cold turkey. Also available in vape form for quick relief. Colin personally uses it for insomnia and severe PTSD. Contains 320mg total cannabinoids per peach: 30mg CBN, 15mg Delta-9 THC, 25mg Delta-8 THC, 100mg CBD, 150mg CBG.

Custom Creations — We design targeted products for individual needs: specific cannabinoid ratios, delivery formats, formulations for vegans, diabetics, unique health circumstances.

TWO PRODUCT FORMATS

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg per mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper: 0.1mL increments for precise dosing
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximately 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual (no separate delta-9 THC listed — THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

When to Use Each Format in Dooly County

Use Case	Recommended Format	Why It Matters for Dooly County
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset for breakthrough moments
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration for all-day or all-night support
Maximum absorption	Sublingual	13-19% bioavailability for efficient use
Portability/discretion	Vape	Compact for travel to Cordele, Macon, or Atlanta
Precise dosing	Sublingual	0.1mL increments let you find your exact dose
Daytime non-psychoactive	Sublingual (raw)	Zero impairment for farm work, driving, machinery
Nighttime psychoactive	Sublingual (decarbed) or Vape	Full potency when impairment isn’t a concern

GENERAL KNOWLEDGE: THE SCIENCE BEHIND EVERY COMPOUND

Research Method and Evidence Weighting

We prioritize evidence in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. This matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes still depend more on reviews, animal work, and in vitro pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH states the strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite/weight-loss indications in HIV/AIDS. Only modest evidence exists for chronic pain and MS symptoms; many other uses remain early-stage [1].
• FDA has not approved the cannabis plant itself for medical use, though purified CBD (Epidiolex) and synthetic THC-like drugs have specific approvals [1].
• Safety concerns repeatedly highlighted include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, and THC-vape lung injury [1].
• NCCIH warns that over-the-counter CBD products may differ from labels and that CBD itself has been associated with decreased alertness, GI effects, liver abnormalities, and drug interactions [1].

CBD (Cannabidiol) — 4,500mg in our formula

Evidence Profile: Strongest human evidence in our formula, especially when studied as purified product [1]-[6].

Best Supported: Purified CBD has the most credible human evidence in seizure disorders, the clearest major-example indication acknowledged by institutional literature [1][2].

Anxiety Research: A 2024 systematic review and meta-analysis covering 316 participants across eight eligible articles reported a statistically significant anxiolytic signal, but authors stressed the clinical sample remains limited and more trials are needed [3].

Pain Research: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded the pain literature is promising but heterogeneous, with trial quality limiting broad analgesic claims [4].

Sleep Research: A 2023 insomnia review found the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures [5].

Safety Concerns: A 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, especially relevant for concentrated oral products and polypharmacy settings [6].

Bottom Line for Dooly County: CBD is the most evidence-developed nonintoxicating cannabinoid we include, but even here, strong evidence concentrates in a few specific indications rather than broad wellness claims [1]-[6].

CBG (Cannabigerol) — 3,000mg in our formula

Evidence Profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from both THC and CBD. Review literature describes interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling — mechanistically interesting but not yet clinically established [7].

Potential Research Areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings [7][8].

Caution: A 2021 pharmacology review explicitly notes that CBG is already being sold commercially while the evidence base remains thin, meaning claims frequently outrun the science [7].

Bottom Line for Dooly County: CBG is a serious research topic, but should be described as a promising minor cannabinoid with limited clinical validation rather than proven therapeutic cannabinoid [7][8].

Delta-8 THC — 6,000mg in our formula

Evidence Profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

Comparative Pharmacology: A 2022 review concluded delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity in animals and humans, but appears less potent than delta-9, likely due to weaker CB1 affinity [9].

Public Health Literature: A 2023 scoping review found the delta-8 evidence base is still dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. The review also noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

Manufacturing Context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is why product-byproduct and lab-testing questions matter [11].

Bottom Line for Dooly County: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

THCa (Tetrahydrocannabinolic Acid) — 1,500mg in our formula

Evidence Profile: Important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].

What It Is: THCa is the acidic precursor of THC and may represent a very large share of THC-related content in raw plant material. The key formulation issue is that THCa decarboxylates into THC during heating and can change over time during storage and processing [12].

Psychoactivity: The major review source stresses that THCa itself does not produce psychoactive effects associated with THC in humans, but this distinction only holds if the molecule stays in its acidic form and is not substantially decarboxylated [12].

Research Status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes [12].

Bottom Line for Dooly County: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim about THCa needs to account for possible conversion into THC [12].

Delta-9 THC — 90mg in our formula

Evidence Profile: Strongest human evidence of the psychoactive cannabinoids listed here, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally Best Supported: NCCIH identifies THC-containing cannabinoid medicines as relevant to chemotherapy-related nausea/vomiting, appetite/weight loss in HIV/AIDS, and some MS- and pain-related outcomes, while stressing many other uses remain uncertain [1].

Pain Evidence: A 2022 systematic review of cannabis-based products for chronic pain found high-THC products or comparable THC:CBD ratios may provide short-term pain benefit, but also increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].

Pharmacokinetics: Inhaled THC produces effects within seconds to minutes, peaks in 15-30 minutes, and tapers over a few hours. Oral THC has later onset, later peak, and longer duration, which matters for both benefit and overconsumption risk [14].

Mental Health Risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression in nontherapeutic settings [15].

Broader Safety: Institutional literature describes anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury concerns [1][14][15].

Bottom Line for Dooly County: Delta-9 THC has legitimate therapeutic relevance in some settings, but also carries the clearest intoxication, psychiatric, and dose-related safety liabilities in our formula [1][13]-[15].

CBN (Cannabinol) — 750mg in our formula

Evidence Profile: Weak human evidence; marketing has clearly moved ahead of the data [12][16][17].

What It’s Marketed For: Sleep and sedation. That reputation is widespread, but clinical support is far thinner than the market suggests [16][17].

Best Direct Review: The 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN [16].

Broader Sleep Literature: A 2024 updated review on cannabis and sleep concluded overall cannabinoid sleep research still does not match the scale of real-world use, and the need for better-designed, adequately powered trials remains substantial [17].

Chemical Context: THC can degrade toward CBN under certain conditions, which helps explain why CBN is often discussed in aging or oxidized cannabis chemistry contexts [12].

Bottom Line for Dooly County: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence [16][17].

CBC (Cannabichromene) — 750mg in our formula

Evidence Profile: Emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].

Pharmacology: The 2024 focused review on CBC argues it has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

Older Literature: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these signals are not yet strong evidence for patient-facing claims [19].

Safety Caveat: The 2024 CBC review explicitly notes over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom Line for Dooly County: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not already-validated clinical actives [18][19].

Terpenes: The Flavor and Potential Effects

Important Context: Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene — Citrus-bright aroma

Evidence Profile: Largely review and preclinical, with useful safety literature [20]-[22].

Potential Activity: A 2021 review describes limonene as multifunctional with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possibilities, but most claims come from nonhuman or non-cannabis literature [21].

Safety Note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22].

Bottom Line for Dooly County: Limonene is biologically active, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

Myrcene — Earthy, musky aroma

Evidence Profile: Mostly preclinical, very limited human evidence [20][23].

Research Summary: The 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties, but explicitly states human studies are lacking [23].

Interpretation Caution: Myrcene is often invoked as a proven sedating terpene that explains couch-lock or sleep effects. That is a stronger claim than human evidence currently supports [20][23].

Bottom Line for Dooly County: Myrcene is plausible but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene — Pepper/spice aroma

Evidence Profile: Among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].

Why It Stands Out: A 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist, unusual and especially relevant when discussing cannabis terpenes in pharmacologic terms [24].

Research Themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions are discussed, but human clinical confirmation remains limited [24].

Bottom Line for Dooly County: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but should not be described as clinically proven for common attributed outcomes [24].

Pinene — Forest-fresh aroma

Evidence Profile: Promising preclinical literature, weak human clinical confirmation [20][25].

Brain-Health Framing: The 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].

Interpretation Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

Bottom Line for Dooly County: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool — Floral, lavender aroma

Evidence Profile: Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research Summary: Linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts while emphasizing lack of robust human trials [25].

Safety Note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Bottom Line for Dooly County: Linalool is scientifically credible as bioactive, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene — Earthy, woody aroma

Evidence Profile: Translationally interesting, but early [20][27].

Scoping-Review Findings: A 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation Caution: Those findings are valuable for hypothesis generation but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Bottom Line for Dooly County: Humulene is one of the more interesting terpene research targets, but remains far from clinically settled [27].

Terpinolene — Piney, fruity, sparkling aroma

Evidence Profile: One of the least clinically characterized terpenes in our formula [20][28].

Systematic-Review Findings: The 2021 terpinolene review screened 2,449 records and included 57 studies, concluding terpinolene has reported biological effects but the evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials [28].

Interpretation Caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].

Bottom Line for Dooly County: Terpinolene is biologically interesting but especially underdeveloped clinically [20][28].

Research Limits and Interpretation

For Dooly County residents evaluating cannabis claims, understand these five critical rules:

1. Evidence is highly uneven. CBD and delta-9 THC can support the most detailed statements; the rest require more caution [1]-[29].

2. Extract/molecule/synthetic/terpene data aren’t interchangeable. One common error is letting evidence from one category stand in for another.

3. Minor cannabinoids and terpenes are commercially interesting BECAUSE they’re underexplored, but that also means claims around them often become inflated.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world products [1][10][11][14].

5. For THCa, chemistry is destiny: storage and heating can change the actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid

Overstatement: CBN is a clinically proven sleep cannabinoid.
More Accurate: Specific sleep evidence for CBN remains weak, with no strong validated-trial base [16][17].

Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
More Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

Overstatement: Terpenes in general have proven entourage effects in patients.
More Accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: THCa is always nonpsychoactive.
More Accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

Overstatement: Delta-8 THC is safe because it’s hemp-derived.
More Accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Dooly County Residents

• CBD and delta-9 THC are the most evidence-developed actives in our formula.
• Delta-8 THC is not trivial or purely mild; it’s a psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing; raw vs. heated forms are pharmacologically different.
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD and THC.
• Terpene claims should be careful; while they contribute to aroma and potential bioactivity, compound-specific human therapeutic claims are often ahead of the evidence.

RSO SUBLINGUAL OIL FORMULA

Complete Open-Source Formula — Published for Dooly County Residents

Cannabinoid	Amount (mg)
CBD	4,500
CBG	3,000
Delta-8 THC	6,000
THCa	1,500
Delta-9 THC	90
CBN	750
CBC	750
Total Cannabinoids	16,590

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Carrier: Organic MCT oil
• Volume: 30mL (1 fl oz)
• Concentration: 553mg total cannabinoids per mL
• Dosing: Graduated dropper in 0.1mL increments

RSO VAPE CARTRIDGE FORMULA

Complete Open-Source Formula — Published for Dooly County Residents

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Volume: 1 gram
• Compatibility: 510-thread universal battery

TERPENE PROFILE (BOTH PRODUCTS)

• Limonene — Citrus-bright aroma
• Myrcene — Earthy, musky base note
• Caryophyllene — Pepper/spice warmth
• Pinene — Forest-fresh clarity
• Linalool — Floral, lavender calm
• Humulene — Earthy, woody depth
• Terpinolene — Piney, fruity sparkle

CONDITION-SPECIFIC USAGE CONTEXT FOR DOOLY COUNTY

Important Disclaimer for Dooly County Residents: The following usage contexts are informed by cannabinoid research cited above and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. If you’re receiving treatment at Crisp Regional Hospital, seeing a specialist in Macon, or working with a doctor in Vienna, discuss cannabinoid use with them first.

General Titration Principle for Dooly County: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: Delta-8 antiemetic [9], delta-9 nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory benefits without impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual — pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

For Dooly County’s agricultural workers — those long days in peanut fields, the repetitive strain from operating equipment, the chronic back pain that comes with physical labor — this multi-pathway approach addresses inflammation through several mechanisms simultaneously.

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — the dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN — above the 20mg threshold associated with reduced sleep disturbance in published research
• Evidence: CBN sleep [16][17], cannabis and sleep review literature

Dooly County’s quiet nights can be long, especially for those dealing with pain, anxiety, or PTSD. Our sublingual oil’s 4-6 hour duration supports sleep architecture through the night.

Anxiety and Stress

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

For Dooly County residents facing financial stress from crop fluctuations, healthcare costs, or the isolation that comes with rural living, non-psychoactive daytime relief can be life-changing.

DELIVERY AND GLOBAL ACCESSIBILITY — REACHING DOOLY COUNTY

Houston Same-Day Delivery (Reference for Comparison)

We operate the only same-day RSO delivery system in Houston, with free delivery to the Texas Medical Center (60+ institutions including MD Anderson, Memorial Hermann, Methodist, Texas Children’s), $5 inner loop, $10 within Beltway 8, $15 to Greater Houston suburbs, $20-25 to extended region (60 miles). Typical turnaround: 2-6 hours depending on zone.

Nationwide Shipping to Dooly County, Georgia

We ship to all 50 states where Farm Bill-compliant products are legal, including Georgia.

Shipping Options to Dooly County:

• USPS Priority Mail: 2-3 business days to Vienna, Unadilla, or anywhere in Dooly County
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible
• Tracking provided: For all orders
• Temperature-stable packaging: For Georgia summers
• Signature-required option: Available for security

International Shipping

We ship internationally and have delivered to multiple continents. The THCa legal framework makes this possible: because our product contains less than 0.3% delta-9 THC at sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

All international packages include full documentation, Certificates of Analysis, and receipts for customs. Customers are responsible for verifying legality in their jurisdiction and accept all customs and legal risk.

The significance for Dooly County residents with family overseas: a cancer patient in Germany, a chronic pain patient in Australia, or a veteran in the UK can now access the same clinical-strength multi-cannabinoid RSO formula reaching your doorstep in Dooly County. Rick Simpson could never ship his oil anywhere — it was Schedule I. We’ve built a product that can move across borders legally.

Our PANDEM1C SEO technology — a proprietary system with 14 million distinct geopolitical locations in its database and over 300 AI models — drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language.

COMPETITIVE COMPARISON FOR DOOLY COUNTY RESIDENTS

OilWell RSO vs. Georgia’s TCUP Dispensary RSO

If you were to drive from Dooly County to a TCUP dispensary in Macon or Atlanta (a 1-2 hour drive each way), here’s what you’d find:

Dimension	Georgia TCUP Dispensary RSO	OilWell RSO
Cannabinoid profile	THC-only (~420mg THC per 0.5g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	0mg	3,000mg
CBN content	0mg	750mg
CBC content	0mg	750mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	TCUP medical card with qualifying condition (cancer, PTSD, terminal illness, etc.)	Age 21+ only, no medical card required
Qualifying conditions	Restrictive list — most Dooly County residents don’t qualify	None required
Delivery	Must drive 1-2 hours to dispensary	Shipped directly to your Dooly County address
Farm Bill compliant	No — state medical program	Yes — less than 0.3% delta-9 THC

OilWell RSO vs. Hemp CBD RSO (e.g., Online Retailers)

Dimension	Typical Hemp CBD RSO (10mL, 1,000mg)	OilWell RSO (30mL, 16,590mg)
Total cannabinoids	1,000mg	16,590mg
CBD content	~950mg	4,500mg
CBG content	15.5mg	3,000mg
CBN content	0.7mg	750mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg (converts to ~1,315mg delta-9 THC)
Psychoactive option	No meaningful effect	Yes — via THCa decarboxylation and delta-8 THC
Price	$40-50	$129.99

HOW THE OILWELL FORMULAS CONNECT TO THE EVIDENCE

Every cannabinoid and terpene in our formulas has its evidence profile documented in the GENERAL KNOWLEDGE section above. We anchor our formulations to per-compound evidence summaries and explain what is well-supported, emerging, or overstated.

Our RSO guide page makes specific research claims about individual cannabinoids and terpenes. This document provides the source evaluation context — the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework.

We do not exempt ourselves from the same evidence standards applied to the broader field. That is intentional. As Colin said in 2019: people deserve the best possible version of information so they can give it a fair shot and decide whether it’s right or wrong for them.

This document is the research foundation for that position.

OILWELL CANNABIS IS MORE THAN A BRAND — it is a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that has defined us from the day Bentley got up, walked across the room, and brought his ball to play.

FINAL WORDS FOR DOOLY COUNTY

If you’re reading this from your home in Vienna, from a farm near Pinehurst, or from anywhere in Dooly County, you now have the most complete, honest, science-based education about Rick Simpson Oil available anywhere. You understand:

• The history of Rick Simpson and what traditional RSO actually was
• How our modern, legal, multi-cannabinoid formula differs and why those differences matter for your safety
• The actual evidence for every compound in our formula
• How to access our products in Dooly County legally and discreetly
• How to use them responsibly for your specific conditions

You don’t need a medical card. You don’t need to drive to Macon or Atlanta. You don’t need to settle for low-quality, untested products. You can have clinical-strength, lab-tested, seven-cannabinoid RSO shipped directly to your door in Dooly County.

Whether you’re a veteran dealing with PTSD, a cancer patient looking for support during chemo, a farmer with chronic pain from years of physical labor, or simply someone who wants to sleep through the night again — we’re here to help you make an informed decision.

Order today: Visit oilwellcbd.com or call (832) 416-2816. We ship to Dooly County, Georgia, and we stand behind every product with the integrity that comes from having lived through the struggles you’re facing.

Your health is worth honest answers. Your trust is worth earning. Your community in Dooly County deserves nothing less.

OILWELL CANNABIS
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816
[email protected]
https://oilwellcbd.com/

Age Requirement: 21+ for all RSO products
FDA Disclaimer: These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult a healthcare provider before use.
Safety Warning: May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Keep out of reach of children.
Legal Notice: Buyer is responsible for verifying compliance with local laws. Products contain less than 0.3% delta-9 THC by dry weight and are Farm Bill compliant. Void where prohibited by law.